FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

High Concentration topics
High Concentration
Carbon Dioxide
Semiconductor Device
Semiconductor
Coercivity
Molybdenum Trioxide
Molybdenum
Persistence
Fungicidal
Semiconductor Substrate
Regenerative
Quantitative
Ultraviolet Radiation
Ultraviolet
Cross Section

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

High Concentration patents



      
           
This page is updated frequently with new High Concentration-related patent applications. Subscribe to the High Concentration RSS feed to automatically get the update: related High RSS feeds. RSS updates for this page: High Concentration RSS RSS


Recovery and purification of monovalent salt contaminated with divalent salt

Protecting element having first and second high concentration impurity regions separated by insulating region and method

Date/App# patent app List of recent High Concentration-related patents
08/14/14
20140228436
 Organ protection solution and its method of use patent thumbnailOrgan protection solution and its method of use
An organ protectant solution which is intravenously administered includes a high concentration of cell-impermeant molecules and at least one oncotic agent. The cell-impermeant molecules preferentially load into the interstitial space and the oncotic agent(s) is/are restricted to the vasculature space.
08/14/14
20140227242
 Compositions containing non-polar compounds patent thumbnailCompositions containing non-polar compounds
Provided are compositions and methods for producing stable foods and beverages that contain high concentrations of additives such as essential fatty acids, including omega-3 fatty acids, omega-6 fatty acids, conjugated fatty acids, and other fatty acids; phytochemicals, including phytosterols and carotenoids; oil soluble vitamins; alpha lipoic acid; other oils; and coenzymes, including coenzyme q10, and other oil-based additives.. .
08/14/14
20140227151
 Recovery and purification of monovalent salt contaminated with divalent salt patent thumbnailRecovery and purification of monovalent salt contaminated with divalent salt
A method and system for improving the quality and quantity of a soluble salt recovered from the supernatant produced when concentrated solutions are mixed to precipitate an insoluble salt are disclosed. Liquid residual, or supernatant, contains salt that is reusable in the regeneration solution of ion removal devices such as ion exchange or electrodialysis metathesis (edm).
08/14/14
20140225227
 Protecting element having first and second high concentration impurity regions separated by insulating region and method patent thumbnailProtecting element having first and second high concentration impurity regions separated by insulating region and method
With a microwave fet, an incorporated schottky junction capacitance or pn junction capacitance is small and such a junction is weak against static electricity. However, with a microwave device, the method of connecting a protecting diode cannot be used since this method increases the parasitic capacitance and causes degradation of the high-frequency characteristics.
08/14/14
20140225217
 Semiconductor device and method of manufacturing the same patent thumbnailSemiconductor device and method of manufacturing the same
A semiconductor device and method of manufacturing the semiconductor device is disclosed in which the tradeoff relationship between the eoff and the turning off dv/dt is improved at a low cost using a trench embedding method. The method comprises a step of forming a parallel pn layer that is a superjunction structure using a trench embedding method and a step of ion implantation into an upper part of an n type semiconductor layer, i.e., an n type column, forming a high concentration n type semiconductor region.
08/14/14
20140224993
 Scintillating organic materials and methods for detecting neutron and gamma radiation patent thumbnailScintillating organic materials and methods for detecting neutron and gamma radiation
Embodiments pertain to a method and apparatus for detection of radiation. Embodiments relate to the detection of fast and/or thermal neutrons.
08/07/14
20140220216
 Beverage composition patent thumbnailBeverage composition
There is provided a beverage composition including a collagen peptide having a high concentration and having moderately acidic taste and excellent flavor in a ph range of the ph 4.0 or less. A beverage composition including 2,000 mg/10 ml or more of a low molecular collagen peptide having an average molecular weight of 3,000 or less and two or more kinds of acidifiers containing phosphoric acid, in which the ph is 4.0 or less..
08/07/14
20140220083
 Cationic oil-in-water emulsions patent thumbnailCationic oil-in-water emulsions
This invention generally relates to cationic oil-in-water emulsions that contain high concentrations of cationic lipids and have a defined oil:lipid ratio. The cationic lipid can interact with the negatively charged molecule thereby anchoring the molecule to the emulsion particles.
07/31/14
20140213542
 Composition containing s-adenosyl-l-methionine with excellent storage stability patent thumbnailComposition containing s-adenosyl-l-methionine with excellent storage stability
The present invention relates to a composition including s-adenosyl-l-methionine; and at least one kind of additive selected from carboxymethylcellulose, hydroxypropylcellulose, soybean polysaccharide, casein sodium, and zein, in which s-adenosyl-l-methionine is extracted from s-adenosyl-l-methionine-containing cells obtained by culturing a microorganism having an ability to produce same, and the content of the additive in the composition falls within the range of 0.05 to 15 times by mass of s-adenosyl-l-methionine in the composition. The present invention provides a composition containing a high concentration of s-adenosyl-l-methionine, which is useful as a water-soluble physiologically active substance, and being excellent in storage stability and bioabsorbability.
07/31/14
20140213451
 Alkoxylated alkylamine quaternary surfactants for glyphosate patent thumbnailAlkoxylated alkylamine quaternary surfactants for glyphosate
The present invention relates to stable glyphosate formulations with improved efficacy by a highly effective alkoxylated alkylamine quaternary surfactant at a very low used level. The alkoxylated alkylamine quaternary surfactant is compatible in all salts of glyphosate formulations (including potassium and ammonium) even at very high concentration (470-600 g a.e./l)..
07/31/14
20140212565
Nutrition beverages
Nutrition beverage compositions including high concentrations of protein are provided. Methods of making nutrition beverage compositions including high concentrations of protein are provided..
07/31/14
20140209033
Litter wizard system
The present invention consists of a two part system for controlling pet odor. The first part is an enzyme spray with a high concentration of microbes that consume ammonia.
07/24/14
20140206071
Metabolically engineered yeasts for the production of ethanol and other products from xylose and cellobiose
The present invention provides yeast cells that produce high concentrations of ethanol, culture media and bioreactors comprising the yeast cells, and methods for making and using the yeast cells in efficiently producing ethanol.. .
07/24/14
20140205777
Articles of manufacture made from pulp composition
One aspect of the invention relates to an article of manufacture made from a pulp composition comprising an arf pulp. In one embodiment, the pulp composition made from agricultural renewable fibers (arf) having low kappa number with unexpected quality sufficient for papermaking (e.g., high strength parameters and high freeness).
07/24/14
20140205659
Controlled release pharmaceutical compositions comprising a fumaric acid ester
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g.
07/24/14
20140205650
Coated suppositories
The invention relates to coating of suppositories containing free unsaturated fatty acid, fatty acid ethyl ester and fatty acid monoglyceride that are susceptible to oxidative degradation. The coating retards oxidative degradation of unsaturated fatty acids and gives the suppository a non-oily and smooth surface.
07/24/14
20140202573
Implementing pre-treatment of water cooling hoses to increase reliability
Pre-treated water cooling hoses and a method for implementing pretreatment of water cooling hoses for increased reliability are provided. Pretreatment of the water cooling hoses includes attaching the water cooling hose to a water cooling system, filling the water cooling system with a high concentration corrosion inhibitor solution, and running the system for an extended time to saturate the attached hose with the high concentration corrosion inhibitor..
07/17/14
20140200338
Oligonucleotides containing high concentrations of guanine monomers
This invention pertains to methods for oligonucleotide synthesis, specifically the synthesis of oligonucleotides that contain a high content of guanine monomers. In more detail, the invention relates to a method for coupling a nucleoside phosphoramidite during the synthesis of an oligonucleotide to a universal support, to a first nucleoside, or to an extending oligonucleotide.
07/17/14
20140200273
Controlled release pharmaceutical compositions comprising a fumaric acid ester
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g.
07/17/14
20140200272
Controlled release pharmaceutical compositions comprising a fumaric acid ester
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g.
07/17/14
20140199393
Controlled release pharmaceutical compositions comprising a fumaric acid ester
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g.
07/17/14
20140199392
Controlled release pharmaceutical compositions comprising a fumaric acid ester
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g.
07/17/14
20140199390
Controlled release pharmaceutical compositions comprising a fumaric acid ester
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g.
07/17/14
20140199388
Controlled release pharmaceutical compositions comprising a fumaric acid ester
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g.
07/17/14
20140199387
Controlled release pharmaceutical compositions comprising a fumaric acid ester
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g.
07/17/14
20140199386
Controlled release pharmaceutical compositions comprising a fumaric acid ester
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g.
07/10/14
20140193495
Controlled release pharmaceutical compositions comprising a fumaric acid ester
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g.
07/10/14
20140193390
High concentration alpha-glucosidase compositions for the treatment of pompe disease
The present application provides for compositions comprising high concentrations of acid α-glucosidase in combination with an active site-specific chaperone for the acid α-glucosidase, and methods for treating pompe disease in a subject in need thereof, that includes a method of administering to the subject such compositions. The present application also provides methods for increasing the in vitro and in vivo stability of an acid α-glucosidase enzyme formulation..
07/10/14
20140193359
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
Disclosed are methods, compositions and uses of high concentration antibody or immunoglobulin formulations for subcutaneous, intramuscular, transdermal or other local (regional) administration, in a volume of than 3, less than 2 or less than 1 ml. Preferably, the formulation contains a high concentration formulation (hcf) buffer comprising phosphate, citrate, polysorbate 80 and mannitol at a ph of about 5.2.
07/10/14
20140191313
Semiconductor device and method of manufacturing the same
Provided is a semiconductor device formed with a trench portion for providing a concave portion in a gate width direction and with a gate electrode provided within and on a top surface of the trench portion via a gate insulating film. At least a part of a surface of each of the source region and the drain region is made lower than other parts of the surface by removing a thick oxide film formed in the vicinity of the gate electrode.
07/10/14
20140191157
Composition for acid gas tolerant removal of mercury from a flue gas
Compositions and method useful for removal of mercury from a flue gas stream with relatively high concentrations of acid gas precursors and/or acid gases. The method includes contacting the flue gas stream with a sorbent composition comprising a sorbent material and a multi-functional agent, where the multi-functional agent includes a compound having a metal of valency 3 or higher.
07/03/14
20140186888
Method for enhancing the production yield of human papillomavirus l1 protein
This invention is a method for improving production yield of hpv l1 protein including the phase of culturing cell expressing hpv l1 protein in a medium containing high concentration of carbon source. According to the culture method using a medium containing highly concentrated carbon source of this invention, the production yield of hpv l1 protein can be not only remarkably increased but also the immunogenicity of the produced hpv l1 protein is significantly increased..
07/03/14
20140186625
Composition for acid gas tolerant removal of mercury from a flue gas
Method and compositions useful for removal of mercury from a flue gas stream with relatively high concentrations of acid gas precursors and/or acid gases. The method includes contacting the flue gas stream with a multi-functional agent, where the multi-functional agent includes a salt having a cation of valency 3 or higher.
07/03/14
20140186429
Recombinant protein, pharmaceutical composition containing the same, and method of biosynthesizing
The present invention provides a method of biosynthesizing a recombinant protein containing the biologically active peptide, the pharmaceutical composition containing the recombinant protein as well as the preparation of the recombinant protein. Simply speaking the consecutively multiple copies of the bioactive peptide are replaced in the amino acid sequence of a recombinant protein (so called peptide-protein).
07/03/14
20140186373
Antibody formulation
Anti-baffr antibodies are formulated as lyophilisate or liquid formulation. The lyophilisates can be reconstituted to give a solution with a high concentration of the antibody active ingredient for delivery to a patient without high levels of antibody aggregation.
07/03/14
20140186278
Anhydrous multiphase gel system
An anhydrous multiphase gel system consisting of an outer lipid matrix and an inner phase gelled by means of a polymer is described, which can be obtained by a) melting the lipid phase with the formation of a liquid lipid phase, b) mixing and homogenizing polymers or polymer blends capable of swelling with the formation of a polymer phase to be dispersed, c) combining the polymer phase with the liquid lipid phase and homogenizing the phases, and d) cold stirring the phase mixture until a solid gel-like mixed structure of the entire system is formed. The anhydrous multiphase gel system is particularly suitable for taking up difficulty soluble active substances in high concentration and for providing topical and transdermal applications.
07/03/14
20140183682
Avalanche photodiode-type semiconductor structure with low response time and process for producing such a structure
The invention relates to an avalanche photodiode-type semiconductor structure (1) intended to receive electromagnetic radiation in a given wavelength. The structure comprises a first semiconductor zone (210) with a first type of conductivity with a first longitudinal face (201), said first zone (210) being made of mercury-cadmium telluride of the cdxhg1-xte type with a cadmium proportion x that is varied.
07/03/14
20140182801
Pulp composition
One aspect of the invention relates to a pulp composition made from agricultural renewable fibers (arf) having low kappa number with unexpected quality sufficient for papermaking (e.g., high strength parameters and high freeness). Another aspect of the invention relates to an arf pulp having iso brightness of 60% or higher, and unexpected quality sufficient for papermaking (e.g.
06/26/14
20140178479
Concentrated felbamate formulations for parenteral administration
Formulations of a neuroprotective agent for parenteral administration are described herein. The formulation is in the form of a concentrated (supersaturated) solution or a concentrated suspension of microparticles.
06/26/14
20140178294
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
Disclosed are methods, compositions and uses of high concentration antibody or immunoglobulin formulations for subcutaneous, intramuscular, transdermal or other local (regional) administration, in a volume of than 3, less than 2 or less than 1 ml. Preferably, the formulation contains a high concentration formulation (hcf) buffer comprising phosphate, citrate, polysorbate 80 and mannitol at a ph of about 5.2.
06/26/14
20140178259
Micro-channel water-gas shift reaction device having built-in flow-through-type metal catalyst
The present invention relates to a micro-channel water-gas shift (wgs) reaction device for wgs for generating hydrogen and pre-combustion carbon capture and storage (ccs) from coal gasification, the device using a micro-channel heat exchanger and through-type metal catalyst capable of rapidly dissipating heat generated during single-stage wgs reaction of high concentration co in a high temperature space.. .
06/26/14
20140174680
Pulping processes
A pulping process comprises using a high concentration of anthraquinone (aq). The pulping process is capable of providing a pulp having low kappa number with unexpectedly high strength.
06/19/14
20140171520
Highly soluble stevia sweetener
A method for making highly soluble stevia sweetener compositions is described. The resulting sweetener compositions readily provide high concentration solutions, and also possess superior taste qualities.
06/19/14
20140171509
Non-aqueous patch
Non-aqueous patches comprising lidocaine, which is not dissolved and is present in a crystalline state, have poor permeability to the skin. Therefore, non-aqueous patches have a high concentration of lidocaine.
06/19/14
20140170719
Microorganism and method for lactic acid production
The present invention relates generally to compositions and methods for producing lactic acid using a lactic acid producing microorganism. More specifically, the present invention relates to methods for producing lactic acid with high yield, high concentration and high volumetric productivity through biological fermentation by enterococcus faecalis, or recombinant microorganisms transformed to produce lactate dehydrogenase using the lactate dehydrogenase-encoding genes derived from e.
06/12/14
20140162395
Method for manufacturing solar cell
A method of manufacturing a solar cell is disclosed. The method includes forming a dielectric film on a semiconductor substrate doped with a first conductive type impurity, exposing a high concentration doping region of a predetermined selective emitter by partially removing the dielectric film, and ion-implanting a second conductive type impurity into a front surface of the semiconductor substrate with the dielectric film formed thereon to form a high concentration doping layer in the semiconductor substrate to correspond to the high concentration doping region and to form a low concentration doping layer in the semiconductor substrate to correspond to a region in which the dielectric film is formed..
06/12/14
20140159150
Semiconductor device and semiconductor device manufacturing method
In aspects of the invention, an n-type epitaxial layer that forms an n− type drift layer is formed on the upper surface of an n-type semiconductor substrate formed by being doped with a high concentration of antimony. A p-type anode layer is formed on a surface of the n− type drift layer.
06/12/14
20140159106
Power semiconductor device and method for manufacturing the same
There is provided a power semiconductor device, including: a first conductive type drift layer, a second conductive type termination layer formed on an upper portion of an edge of the drift layer, and a high concentration first conductive type channel stop layer formed on a side surface of the edge of the drift layer.. .
06/12/14
20140157987
Fe(ii)-substituted beta type zeolite, gas adsorbent containing same and method for producing same, and method for removing nitrogen monoxide and hydrocarbon
To provide an fe(ii)-substituted beta type zeolite which has been ion-exchanged with fe(ii) ions and can effectively adsorb and remove nitrogen monoxide or hydrocarbon contained in gas to be cleaned, even if oxygen is present in the gas at a high concentration or the temperature of the gas is low. In the fe(ii)-substituted beta type zeolite, a ratio of sio2/al2o3 is preferably 10 to 18, a bet specific surface area is preferably 400 m2/g to 700 m2/g, a micropore specific surface area is preferably 290 m2/g to 500 m2/g, and a micropore volume is preferably 0.15 cm3/g to 0.25 cm3/g.
06/05/14
20140151277
Fluid purification system
A fluid purification system includes a reaction tank which purifies a purification target fluid by decomposing an organic substance in a purification target fluid with an oxidation reaction while heating and pressurizing a mixed fluid of the purification target fluid and an oxidant; a crusher which crushes an organic solid waste so as to obtain an organic crushed product; and a mixer which mixes the organic crushed product and liquid so as to obtain high concentration organic slurry.. .
06/05/14
20140151041
Foaming composition with wettability modifying and corrosion inhibitory properties for high temperature and ultra-high salinity
The present invention relates to a method of obtaining and using foaming compositions with wettability-modifying and corrosion inhibitory properties that control the channeling of fluids in naturally fractured carbonate reservoirs, favorably alter the rock wettability in crude oil enhanced recovery processes and control uniform corrosion problems occurring in production rigs under high temperature and ultra-high salinity conditions by the synergistic effect resulting from the supramolecular interaction of alkyl amido propyl hydroxysultaines or alkyl hydroxysultaines with sodium alkyl hydroxysulfonates and sodium alkenyl sulfonates having the formula (1). The foaming compositions with wettability-modifying and corrosion inhibitory properties are tolerant to high concentrations of divalent ions such as calcium, magnesium, strontium and barium and are suitable for use in the reservoir, seawater and/or congenital water characteristic of the reservoir for transporting the crude oil from the reservoir..
05/29/14
20140148634
Method and apparatus for recovering ethylene from fluidized catalytic cracking (fcc) off-gas
A method and apparatus for concentrating and recovering ethylene from the off-gas from an apparatus which produces gasoline, propylene and the like by fluidized catalytic cracking (fcc) of heavy oils such as atmospheric residue, generated in a crude oil refining process, is provided. The method and apparatus can reduce the amount of ethylene rinse in the subsequent ethylene displacement desorption process by increasing the ethylene purity of a raw material gas and reducing the concentration of weakly adsorbing components in the raw material gas and can reduce the loss of a desorbent during a distillation process for separating the desorbent from the weakly adsorbing components.
05/29/14
20140147956
Method for manufacturing solar cells, attenuating lid phenomena
To reduce degradation, by the lid effect, of the conversion efficiency of photovoltaic cells made of crystalline silicon, one or more steps of controlled introduction of voids into the silicon are carried out by one or more steps chosen from among: siliciding, nitriding, ion implantation, laser irradiation, mechanical bending stress applied on one face of the silicon substrate, in combination with a temperature promoting the formation of voids in the substrate. These voids make it possible to reduce the level of interstitial oxygen by an effect of diffusion of vo complexes and precipitation of oxygen.
05/29/14
20140147915
Culture device
The culture device (100, 200) for culturing algae includes a culture pond (110) including an opening (112) on an upper side thereof and accommodating an alga solution (m) as a culture solution containing algae; a sheet (130) having optical transparency and flexibility, the sheet sealing at least a portion of the opening (112) of the culture pond (110); and a gas supply unit (124, 160, 212) used to supply high concentration co2 gas having a higher concentration of carbon dioxide than that of the atmosphere, between the culture pond (110) and the sheet (130). A gas storage space (g) to store gas between a liquid surface (114) of the alga solution (m) and the sheet (130) is formed by at least part of the supplied high concentration co2 gas..
05/22/14
20140142237
High solids content dendrimer polymer composition
The present invention relates to a polymer composition comprising: (i) one or more dendritic polymers; and (ii) a reactive diluent that is capable of being chemically coupled to the functional groups of the dendritic polymers, wherein when the dendritic polymer is coupled to the reactive diluent in the presence of a cross-linker, a polymerized solid is formed at high concentrations in a liquid medium. The present invention further relates to methods of preparing the polymer composition and its use in forming coatings..
05/22/14
20140141008
Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
The invention provides a liquid pharmaceutical formulation which does not include nacl and comprises more than 20 mg of a polyol and at least about 100 mg/ml of a human anti-tnf-alpha antibody, or antigen-binding portion thereof. The invention provides a high concentration antibody formulation having long-term stability and advantageous characteristics for subcutaneous administration..
05/22/14
20140141007
Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
The invention provides a liquid pharmaceutical formulation which does not include nacl and comprises more than 20 mg of a polyol and at least about 100 mg/ml of a human anti-tnf-alpha antibody, or antigen-binding portion thereof. The invention provides a high concentration antibody formulation having long-term stability and advantageous characteristics for subcutaneous administration..
05/22/14
20140138737
High voltage mosfet diode reverse recovery by minimizing p-body charges
This invention discloses a method for manufacturing a semiconductor power device in a semiconductor substrate comprises an active cell area and a termination area. The method comprises the steps of a) growing and patterning a field oxide layer in the termination area and also in the active cell area on a top surface of the semiconductor substrate b) depositing and patterning a polysilicon layer on the top surface of the semiconductor substrate at a gap distance away from the field oxide layer; c) performing a blank body dopant implant to form body dopant regions in the semiconductor substrate substantially aligned with the gap area followed by diffusing the body dopant regions into body regions in the semiconductor substrate; d) implanting high concentration body-dopant regions encompassed in and having a higher dopant concentration than the body regions e) applying a source mask to implant source regions having a conductivity opposite to the body region with the source regions encompassed in the body regions and surrounded by the high concentration body-dopant regions; and f) etching contact trenches into the source, body contact, and body regions..
05/22/14
20140138313
Water recovery method
A water recovery method for improving water recovery efficiency may include inflowing a low concentration solution including water into an in-series flow path. The in-series flow path may include a plurality of flow paths for a low concentration solution coupled in series.
05/15/14
20140134773
Patterned layer design for group iii nitride layer growth
A method of fabricating a device using a layer with a patterned surface for improving the growth of semiconductor layers, such as group iii nitride-based semiconductor layers with a high concentration of aluminum, is provided. The patterned surface can include a substantially flat top surface and a plurality of stress reducing regions, such as openings.
05/15/14
20140134261
Pharmaceutical compositions comprising capsaicin esters for treating pain and cold sores
The present invention relates to pharmaceutical compositions comprising ester(s) of capsaicin and at least one other agent selected from salicylates, menthol, boswellic acids, dmso, methyl sulfonylmethane, nsaids, corticosteroids, emu oil, opioid agonists and antagonists, nmda antagonists, tramadol, hyaluronic acid, α2δ ligands, santalol, santalyl acetate, amyris alcohol, amyris acetate, aloe vera gel and aloe vera juice, for improved therapeutic properties. Further, the present invention relates to pharmaceutical compositions comprising high concentrations of ester(s) of capsaicin.
05/15/14
20140130717
Method and facility for recovering co2 gas in cement manufacturing facility
To provide a method and facility for enabling co2 gas generated in a cement manufacturing facility to be separated and recovered at a high concentration. To this end, according to the present invention, the calcination of a cement material and the recovery of co2 gas generated in a calciner are performed by one of the following steps of: [1] superheating the cement material before calcination to at least the calcination temperature thereof in a superheating furnace and then mixing the superheated cement material with a new cement material before calcination in a mixer/calciner; [2] mixing, in the mixer/calciner, the cement material before calcination with a part of high-temperature cement clinker discharged from a cement kiln; and [3] using an externally heated calciner..
05/08/14
20140128355
Baclofen solution for low-volume therapeutic delivery
A high concentration baclofen solution is provided suitable for therapeutic use in a medical setting. A high concentration solution of baclofen in multivalent physiological ion solution such as artificial cerebrospinal fluid is provided with concentrations of baclofen of 10 mg/ml.
05/08/14
20140127227
Protein formulations containing amino acids
Provided are stable protein formulations that contain at least one amino acid. In certain embodiments, amino acid combinations either at least two, or three, or four, or more amino acids are included.
05/01/14
20140121645
Methods and apparatus for the cvcs
The present invention provides an indirect method and accompanying apparatus for supplying a high concentration of medicaments, particularly antibiotics, to the nasal sinuses by first loading the medicament into the cerebrospinal venous system (cvcs) via a valsalva maneuver. Because the cvcs is a valveless, three-dimensional closed system, traditional physiological dogma such as veins always draining tissues does not always apply.
05/01/14
20140120210
Lactobacillus plantarum cells with improved resistance to high concentrations of ethanol
Cycloserine resistant mutants of lactic acid bacteria characterized by having improved resistance towards ethanol. The cycloserine resistant mutants of lactic acid bacteria can e.g.
05/01/14
20140120086
Method for preparation of a high concentration liquid formulation of an antibody
The present invention provides a method for preparation of a high concentration liquid formulation (hclf) of an antibody or a fragment thereof. The present invention also relates to a method for stabilizing an anti-cd20 antibody or a fragment thereof in a liquid pharmaceutical formulation.
04/24/14
20140113421
Silicon carbide semiconductor apparatus and method of manufacturing same
A silicon carbide vertical mosfet having low on-resistance and high blocking voltage is provided. For this, a first deposition film (2) of low concentration silicon carbide of a first conductivity type is formed on the surface of a high concentration silicon carbide substrate (1) of a first conductivity type.
04/24/14
20140112979
Methods for producing liposomes
The invention discloses a method for the formation of liposomes by using high shear mixing of aqueous solution of lipid powder; the lipid powder can be produced by any known technique. Components of the liposomes include but are not limited to cationic lipids, immunostimulatory/immunopotentiators and macromolecules as components for the liposome formation.
04/17/14
20140107053
Apples with high polyphenolic content
The invention relates to apples comprising high concentrations of polyphenols, to processes for obtaining said apples and to uses of apples as a method of treatment of prophylaxis of cardiovascular disease, colon cancer and digestive health.. .
04/17/14
20140106040
Antimicrobial agent
There is described a method for the decontamination of (whole) fruit and/or vegetables comprising: (i) an optional first step of pre-washing the fruit and/or vegetables in high concentration of the decontaminant to deal with heavy spoilage; (ii) washing the fruit and/or vegetables in a low concentration of the decontaminant to deal with any residual microbial presence; wherein the decontaminant comprises an acidulant, such as sodium hydrogen sulphate, citric acid, lactic acid and tannic acid.. .


Popular terms: [SEARCH]

High Concentration topics: High Concentration, Carbon Dioxide, Semiconductor Device, Semiconductor, Coercivity, Molybdenum Trioxide, Molybdenum, Persistence, Fungicidal, Semiconductor Substrate, Regenerative, Quantitative, Ultraviolet Radiation, Ultraviolet, Cross Section

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to High Concentration for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for High Concentration with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.8055

3831

3 - 0 - 71